ERLI PLUS XR 12.5/1000MG TAB

ERLI PLUS XR 12.5/1000MG TAB combines empagliflozin and metformin HCl extended release in a single formulation designed for type 2 diabetes management. Empagliflozin works by promoting glucose excretion through urine, while metformin helps reduce blood sugar levels by decreasing hepatic glucose production and improving insulin sensitivity. This dual-action combination offers convenient once-daily dosing with extended-release technology for sustained therapeutic effect throughout the day. Suitable for patients requiring enhanced glycemic control when monotherapy is insufficient.